McKesson acquiring CoverMyMeds for at least $1.1 billion (updated)
McKesson will pay about $1.1 billion, and an additional $270 million is contingent upon CoverMyMeds financial performance the next two years.
Meet Conserus, McKesson’s imaging line for value-based care
McKesson discussed Conserus at last week's RSNA conference in Chicago.
Why Pharma Companies Should Look To Social Media For Better Patient Insight
Healthcare decision-makers, especially at pharmaceutical companies, must prioritize patient input. Data collected from social media listening is a significant step in the right direction.
New McKesson Intelligence Hub seeks to break down payer data silos
The system connects payer networks to providers and payment systems, breaking down data silos and helping to streamline authorization, claims submission and payments.